Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in South Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in South Carolina
| Provider | Medicare | Services |
|---|---|---|
| Snyder, Jason M.D. | $120.89 | 43 |
| Gowdy, John D.O. | $119.93 | 34 |
| Anderson Diagnostic Imaging, Llc | $357.89 | 31 |
| Terlouw, Janet M.D. | $122.95 | 25 |
South Carolina Pricing in Context
In South Carolina, CPT code 19081 (Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth) carries an average Medicare payment of $137.88 — 34% below the national benchmark of $210.47. 120 providers across the state submitted claims for this procedure in 2023, performing 1.1K total services. Individual payments in SC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in South Carolina is $1,098.43, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because South Carolina sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in South Carolina lands near $415.61, with self-pay cash prices typically around $434.71. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cost in South Carolina?
The average Medicare payment for Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in South Carolina is $137.88, which is 34% below the national average of $210.47. Providers in SC typically bill $1,098.43 for this procedure.
What does Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cost with insurance in South Carolina?
With commercial insurance in South Carolina, Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth costs an estimated $415.61. Without insurance, the estimated cash price is $434.71. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in South Carolina?
120 providers in South Carolina billed Medicare for Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in 2023, performing 1.1K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cheaper in South Carolina than the national average?
Yes — Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth costs 34% below the national average in South Carolina. The state average Medicare payment is $137.88 compared to $210.47 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.